Hemo Organic
BSE 524590
11 stories, newest first.
- Standalone results for the quarter ended 30.09.2026 (Unaudited)
- Board approves unaudited Q2 and half-year results; auditor's review carries a qualified opinion
- Board meeting on 17 October 2026 to consider un-audited results for the quarter and half year ended 30 September 2026
- Withdrawal of consent to act as Company Secretary and Compliance Officer; proposed appointment did not take effect
- MCA confirms availability of new name; proposed change of name needs shareholder approval
- Hemo Organic Ltd shareholder buys 24.76% stake, holding rises to 24.76%
- Hemo Organic Ltd shareholder buys 24.76% stake, holding rises to 24.76%
- Board approves change in Main Objects and rise in authorised share capital; defers fund raising
- Board approves Main Objects change and share capital increase; fund-raising proposal deferred
- Board allots 34,00,000 equity shares on conversion of warrants at Rs. 12.50 each
- Board approves allotment of 34,00,000 equity shares on conversion of warrants to two non-promoter investors
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.